Abstract
The sick premature infants have high risk for thrombosis. Although therapeutic options include close observation, anticoagulation, thrombolytic therapy, and thrombectomy, guidelines for the management of neonatal arterial and venous thrombosis vary greatly among different centers. The authors report their experience using low molecular weight heparin (enoxaparin), with safe and successful resolution of right atrial thrombus, in an extremely low birth weight infant.
References
Saxonhouse MA, Burchfield DJ. The evaluation and management of postnatal thromboses. J Perinatol. 2009;29:467–78.
Veldman A, Nold MF, Michel-Behnke I. Thrombosis in the critically ill neonate: incidence, diagnosis, and management. Vasc Health Risk Manag. 2008;4:1337–48.
Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two y survey. Arch Dis Child Fetal Neonatal Ed. 1997;76:F163–7.
Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and International registry. Pediatrics. 1995;96:939–43.
Torres-Valdivieso MJ, Cobas J, Barrio C, et al. Successful use of tissue plasminogen activator in catheter-related intracardiac thrombus of a premature infant. Am J Perinatol. 2003;20:91–6.
Gupta M. Neonatal thrombosis. In: Cloherty JP, Eichenwald EC, Stark AR, editors. Manual of neonatal care. Philadelphia: Lippincott Williams & Wilkins; 2008. pp. 469–82.
Conflict of Interest
None.
Role of Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shin, Jh., Kim, Gn., Kil, Hr. et al. Successful Use of Low Molecular Weight Heparin in Intracardiac Thrombus of an Extremely Low Birth Weight Infant. Indian J Pediatr 80, 779–780 (2013). https://doi.org/10.1007/s12098-012-0840-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-012-0840-7